Does postoperative misoprostol use induce intestinal motility? A prospective randomised double-blind trial

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 47, Issue 5, 2007, Pages 410-414

  Demirci, Fuat ^a   Somunkiran, Asli ^a   Gul, Ozlem Kemik ^a   Demiraran, Yavuz ^a   Ozdemir, Ismail ^a   Gul, Ozgur Baris ^a  

^a DUZCE UNIVERSITY   (Turkey)

Author keywords

Intestinal motility; Misoprostol; Nausea; Postoperative; Prostaglandin E1

Indexed keywords

ANALGESIC AGENT; FENTANYL; MISOPROSTOL; NITROUS OXIDE PLUS OXYGEN; PROPOFOL; ROCURONIUM; SEVOFLURANE;

ABDOMINAL DISTENSION; ADULT; ARTICLE; CHI SQUARE TEST; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG USE; FEMALE; FLATULENCE; FOOD INTAKE; HOSPITALIZATION; HUMAN; HYSTERECTOMY; INTESTINE MOTILITY; INTESTINE SOUND; MAJOR CLINICAL STUDY; NAUSEA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; STATISTICAL SIGNIFICANCE; TIME; VOMITING;

ADMINISTRATION, RECTAL; ADULT; DOUBLE-BLIND METHOD; EATING; FEMALE; GASTROINTESTINAL MOTILITY; HUMANS; HYSTERECTOMY; LENGTH OF STAY; MIDDLE AGED; MISOPROSTOL; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 34548721006     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2007.00767.x     Document Type: Article

References (19)

1. Monk JP, Clissold SP. Misoprostol: A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease. Drugs 1987; 33: 1-30.
2. Kulier R, Gulmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev 2004: (2): CD002855. Review.
3. Neilson JP, Hickey M, Vazquez J. Medical treatment for early fetal death (less than 24 weeks). Cochrane Database Syst Rev 2006 July 19: (3): CD002253. Review.
4. Alfirevic Z, Weeks A. Oral misoprostol for induction of labour. Cochrane Database Syst Rev 2006 April 19: (2): CD001338. Review.
5. Royal College of Obstetricians and Gynecologists (RCOG). The Care of Women Requesting Induced Abortion: National Evidence-Based Clinical Guidelines. London, UK: RCOG Press, 2000.
6. Diab KM, Ramy AR, Yehia MA. The use of rectal misoprostol as active pharmacological management of the third stage of labor. J Obstet Gynaecol Res 1999; 25: 327-332.
7. Bradley SE, Prata N, Young-Lin N, Bishai DM. Cost-effectiveness of misoprostol to control postpartum hemorrhage in low-resource settings. Int J Gynaecol Obstet 2007; 97: 52-56.
8. Derman RJ, Kodkany BS, Goudar SS et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: A randomised controlled trial. Lancet 2006; 368: 1248-1253.
9. Prata N, Hamza S, Gypson R., Nada K, Vahidnia F, Potts M. Misoprostol and active management of the third stage of labor. Int J Gynaecol Obstet 2006; 94: 149-155.
10. Mousa H, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev 2007 January 24: (1): CD003249.
11. Gulmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for prevention of postpartum haemorrhage. Cochrane Database Syst Rev 2004: (1): CD000494. Review.
12. Soffer EE, Metcalf A, Launspach J. Misoprostol is effective treatment for patients with severe chronic constipation. Dig Dis Sci 1994; 39: 929-933.
13. Riviere PJ, Farmer SC, Burks TF, Porreca F. Prostaglandin E2-induced diarrhea in mice: Importance of colonic secretion. J. Pharmacol Exp Ther 1991; 256: 547-552.
14. Kramer RL, Van Someren JK, Qualls CR, Curet LB. Postoperative management of cesarean patients: The effect of immediate feeding on the incidence of ileus. Obstet Gynecol 1996; 88: 29-32.
15. Burrows WR, Gingo AJ Jr, Rose SM et al. Safety and efficacy of early postoperative solid food consumption after cesarean section. J. Reprod Med 1995; 40: 463-467.
16. Isselbacher KJ. The role of arachidonic acid metabolites in gastrointestinal homeostasis. Biochemical, histological and clinical gastrointestinal effects. Drugs 1987; 33 (Suppl. 1): 38-46.
17. Bennett A, Stamford IF, Stockley HL. Estimation and characterization of prostaglandins in the human gastrointestinal tract. Br J Pharmacol 1977; 61: 579-586.
18. Roarty TP, Weber F, Soykan I, McCallum RW. Misoprostol in the treatment of chronic refractory constipation: Results of a long-term open label trial. Aliment Pharmacol Ther 1997; 11: 1059-1066.
19. Khan RU, El-Refaey H, Sharma S, Sooranna D, Stafford M. Oral, rectal and vaginal pharmacokinetics of misoprostol. Obstet Gynecol 2004; 103: 866-870.